Research analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Stock Down 2.2%
Shares of NYSE:MLSS opened at $0.95 on Friday. The firm has a market cap of $74.46 million, a P/E ratio of -13.57 and a beta of 0.93. Milestone Scientific has a 12 month low of $0.58 and a 12 month high of $1.39. The company’s 50-day moving average price is $0.96 and its two-hundred day moving average price is $0.97.
Institutional Trading of Milestone Scientific
Hedge funds and other institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC raised its position in Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. Carnegie Investment Counsel boosted its position in Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after buying an additional 27,412 shares during the last quarter. Renaissance Technologies LLC increased its stake in shares of Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after buying an additional 53,198 shares during the period. Brookwood Investment Group LLC acquired a new stake in shares of Milestone Scientific in the 1st quarter valued at $46,000. Finally, XTX Topco Ltd raised its position in shares of Milestone Scientific by 99.2% during the first quarter. XTX Topco Ltd now owns 34,135 shares of the company’s stock worth $32,000 after acquiring an additional 17,002 shares during the last quarter. Institutional investors and hedge funds own 5.79% of the company’s stock.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
- Five stocks we like better than Milestone Scientific
- The Most Important Warren Buffett Stock for Investors: His Own
- Constellation Powers Up With Reinforced AI Data Center Strategy
- High Flyers: 3 Natural Gas Stocks for March 2022
- Top Analyst-Rated Healthcare Stocks to Watch Now
- Investing In Preferred Stock vs. Common Stock
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.